Infinera Corp (INFN) 23.01 $INFN Global Silicon

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Infinera Corp (INFN) 23.01 $INFN

Global Silicon Photonics (Photonic Wavelength, Optical Modulators, Optical Interconnects, WDMF, LED, and Others) Market 2014 - 2020
M2 - Tue Jul 28, 5:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rnvts3/silicon_photonics) has announced the addition of the "Silicon Photonics Market by Product , Application and by Geography - Global Trends and Forecasts to 2014 - 2020" report to their offering. The silicon photonics market report analyzes the ecosystem of the silicon photonics technology; and the key market, by product, includes silicon photonic waveguides, silicon optical modulators, silicon optical interconnects, wavelength division multiplexer filters, silicon led, silicon photo-detectors, and others. The report also provides the geographic view for the major regions, such as the Americas, Europe, Asia-Pacific (APAC), and the Rest of the World (RoW). It also discusses the burning issues, market dynamics, and winning imperatives for the silicon photonics market. Silicon photonics is garnering more value due to its various features and wide range of applications. It offers various advantages, such as high speed data transfer, data integration, and small factor form; moreover, since it is an emerging technology, it has managed to attract the new industrial users. The telecommunication application held the highest market share in 2013, but the medical application is estimated to experience a better growth in the near future. The silicon photonics market accounts for the highest market share in the developed economies, such as North America. The APAC and European regions are also estimated to grow at a favorable rate during the projected years. The key players in the silicon photonics market include Intel Corporation (U.S.), Hamamatsu Photonics, K.K. (Japan), Finisar Corporation (U.S.), IBM Corp. (U.S.), Luxtera, Inc. (California), ST Microelectronics (Switzerland), 3S Photonics (France), Oclaro Inc. (U.S.), Mellanox Technologies (U.S.), and Infinera Inc. (U.S.), among others. This report provides a detailed view of the silicon photonics market with regard to the products, applications, and geography; it also presents detailed market segmentation, with qualitative and quantitative analysis of each and every aspect of the segmentation. All the numbers in terms of the volume and revenue, at every level of the report, are estimated from 2014 to 2020. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Market, By Product 8 Market By Application 9 Market By Geography 10 Competitive Landscape 11 Company Profiles - 3S Photonics - Das Photonics - Finisar Corp. - Hamamatsu Photonics K.K. - IBM - Infinera Corporation - Intel Corporation - Luxtera Incorporated - Mellanox Technologies - Oclaro, Inc. - Stmicroelectronics. For more information visit http://www.researchandmarkets.com/research/rn..._photonics
IBM: 160.08 (+1.01), MLNX: 45.09 (+0.58), INTC: 29.03 (+0.68), INFN: 23.01 (-0.09)

SmarTrend Watching for Potential Pullback in Shares of Infinera After 8.74% Gain
Comtex SmarTrend(R) - Thu Jul 23, 4:30PM CDT
Infinera (NASDAQ:INFN) traded in a range yesterday that spanned from a low of $22.05 to a high of $24.24. Yesterday, the shares gained 8.7%, which took the trading range above the 3-day high of $21.77 on volume of 8.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
INFN: 23.01 (-0.09)

Stocks Fall For Third Day, But Valeant Tops Buy Point
at Investor's Business Daily - Thu Jul 23, 3:47PM CDT
Stocks fell for a third straight session Thursday on disappointing earnings from economic bellwethers 3M (MMM) and Caterpillar (CAT). The Dow Jones industrial average fell 0.7%, the S&P 500 lost 0.6% and the Nasdaq slid 0.5%. Volume was mixed, rising...
MMM: 151.46 (+2.75), VRX: 257.70 (+0.40), AFOP: 20.36 (-0.45), FCX: 12.44 (+1.07), CAT: 77.99 (+2.67), INFN: 23.01 (-0.09)

Infinera (INFN) Stock Gains on Earnings Beat, Strong Guidance
at The Street - Thu Jul 23, 11:39AM CDT
Infinera (INFN) shares are higher after the company beats analysts' estimates for earnings in the second quarter and issued a strong guidance for the third quarter.
INFN: 23.01 (-0.09)

Stocks Mixed Near Midday; GoPro Aims Higher
at Investor's Business Daily - Thu Jul 23, 11:09AM CDT
Stocks were narrowly mixed near Thursday's halftime amid a swarm of earnings reports and some better-than-expected economic reports. The Nasdaq rose 0.2%, but it was up as much as 0.5% intraday. Chips, fiber optics and security software issues...
GPRO: 62.66 (+1.39), VRX: 257.70 (+0.40), CAT: 77.99 (+2.67), INFN: 23.01 (-0.09)

Infinera Beats Q2 Earnings, Revenue Estimates; Shares Rally - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 23, 11:05AM CDT
Leading optical transport network developer Infinera Corp. (INFN) reported better-than-expected financial numbers in the second quarter of 2015.
ALU: 3.56 (-0.03), CIEN: 25.08 (+0.06), CSCO: 28.23 (+0.02), INFN: 23.01 (-0.09)

Why Infinera Corp. Stock Jumped Today
Anders Bylund, The Motley Fool - Motley Fool - Thu Jul 23, 10:55AM CDT
Image source: Infinera. What's happening: Shares of optical networking specialist Infinera soared as much as 13% in the early Thursday market session. The stock set fresh all-time highs in the process, dating all the way back to October of...
INFN: 23.01 (-0.09)

INFINERA
at Investor's Business Daily - Wed Jul 22, 5:54PM CDT
INFINERA (INFN) Q2 EPS rose 65% to 18 cents, beating by 2 cents. Sales rose 25% to $207.3 mil vs. views of $201.3 mil. The fiber optic network components firm's shares rose 4.8% to 22.31.
INFN: 23.01 (-0.09)

Infinera Boosts Efficiency, Profits in Outrunning Q2 Estimates
Tim Beyers, The Motley Fool - Motley Fool - Wed Jul 22, 4:54PM CDT
Visualizing Infinera's strategy for optimizing network efficiency in the cloud. Credit: Infinera.  Shares of Infinera   inched up 0.09% as of 4:05 p.m. ET Wednesday, as investors contemplated the impact what looks to be significant second-quarter...
INFN: 23.01 (-0.09)

Apple, Microsoft Pull Nasdaq Lower; Cirrus Up Late
at Investor's Business Daily - Wed Jul 22, 4:20PM CDT
Stocks finished lower Wednesday but recovered somewhat after high-profile earnings reports rattled the market early. The Nasdaq fared worst with a 0.7% loss, hurt by earnings weakness in tech giants Apple (AAPL) and Microsoft (MSFT). The S&P 500 fell...
ISRG: 540.13 (-4.02), LEN: 51.06 (+0.50), CMG: 729.08 (-2.36), CRUS: 34.20 (+1.30), MSFT: 45.43 (+0.08), AAPL: 123.80 (+1.03), NVR: 1,458.00 (+11.14), INFN: 23.01 (-0.09)

Infinera tops Street 2Q forecasts
Automated Insights - Wed Jul 22, 4:16PM CDT
SUNNYVALE, Calif. (AP) _ Infinera Corp. (INFN) on Wednesday reported second-quarter net income of $17.9 million.
INFN: 23.01 (-0.09)

Infinera Corporation Reports Second Quarter 2015 Financial Results
Marketwired - Wed Jul 22, 3:15PM CDT
Infinera Corporation (NASDAQ: INFN), provider of Intelligent Transport Networks, today released financial results for the second quarter of 2015 ended June 27, 2015.
INFN: 23.01 (-0.09)

Equinix Selects Infinera Cloud Xpress for Datacenter Interconnect in Hong Kong
Marketwired - Tue Jul 21, 7:00AM CDT
Infinera, provider of Intelligent Transport Networks, announced that Equinix has selected the Infinera Cloud Xpress to interconnect its Hong Kong datacenters. The Infinera Cloud Xpress offers Equinix a platform with hyper-scale density, operational simplicity and low power consumption.
EQIX: 279.83 (+3.19), INFN: 23.01 (-0.09)

Is Infinera (INFN) Poised for Strong Earnings in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 17, 1:25PM CDT
Leading optical transport network developer, Infinera Corporation (INFN) is slated to release its second-quarter 2015 results on Jul 22, 2015, after market close
T: 34.50 (+0.18), CACI: 80.91 (+1.70), VZ: 45.96 (+0.13), INFN: 23.01 (-0.09)

QLogic Falls on Weak Q2 Preliminary Results, Guidance Cut - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 10, 8:30AM CDT
Shares of QLogic Corp. (QLGC) plunged over 21% in yesterday's trading session following the release of its preliminary first quarter fiscal 2016 results.
AMD: 1.74 (+0.12), DGII: 10.04 (-0.02), QLGC: 11.45 (+0.21), INFN: 23.01 (-0.09)

After Yesterday's Decline of 1.84%, Infinera Offers Investors Better Value
Comtex SmarTrend(R) - Thu Jul 09, 5:02PM CDT
Infinera (NASDAQ:INFN) traded in a range yesterday that spanned from a low of $19.54 to a high of $20.90. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $19.78 on volume of 2.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
INFN: 23.01 (-0.09)

Cisco to Acquire MaintenanceNet to Boost Top-Line Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 09, 12:30PM CDT
Cisco Systems (CSCO) recently expressed its intention to acquire a privately-held cloud-based software platform vendor, MaintenanceNet, for $139 million in cash and retention-based incentives.
DGII: 10.04 (-0.02), BRCM: 51.81 (+1.02), CSCO: 28.22 (+0.01), INFN: 23.01 (-0.09)

24.7% Return Seen to Date on SmarTrend Infinera Call (INFN)
Comtex SmarTrend(R) - Tue Jul 07, 10:04AM CDT
SmarTrend identified an Uptrend for Infinera (NASDAQ:INFN) on January 23rd, 2015 at $16.93. In approximately 6 months, Infinera has returned 24.67% as of today's recent price of $21.10.
INFN: 23.01 (-0.09)

Uptrend Call Working As Infinera Stock Rises 24.4% (INFN)
Comtex SmarTrend(R) - Tue Jul 07, 9:57AM CDT
SmarTrend identified an Uptrend for Infinera (NASDAQ:INFN) on January 23rd, 2015 at $16.93. In approximately 6 months, Infinera has returned 24.37% as of today's recent price of $21.05.
INFN: 23.01 (-0.09)

AntriaBio names David F. Welch PhD to board
M2 - Tue Jun 30, 5:46AM CDT
AntriaBio Inc (OTC:ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies, announced on Monday that it has appointed David F. Welch, PhD to the company's board of directors.
INFN: 23.01 (-0.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 307

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 211

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 246

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 694

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 63

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 239

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 180

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

b1BANK Partners with Spiral to Enhance Community Banking Impact

Updated Category News Views 97

Enhanced Financial Wellness through Partnership NEW YORK--Today, Spiral, a personalized banking platform, announced a significant partnership with b1BANK, established as a community-focused banking institution. Through this collaboration, the two organizations aim to enhance financial wellness for customers, leveraging b1BANK's dedication to innovative banking solutions...

Continue Reading
AM Best Explores Trends Influencing For-Hire Trucking Industry

Updated Category News Views 168

Insights from AM Best's Latest Webinar on Trucking Trends Viewers can now delve into the highlights from the enlightening webinar hosted by AM Best, titled "For-Hire Trucking: The Risky Road Ahead." This event focused on the intricacies and challenges within the transportation-for-hire trucking sector, providing expert insights into risk management strategies and the...

Continue Reading
BitMart's Creative Campaign to Ignite Offline Crypto Engagement

Updated Category News Views 135

Introducing the Fox Hunt Delivery Campaign BitMart, a leading global cryptocurrency exchange, is excited to announce the launch of the Fox Hunt Delivery Campaign, a unique initiative aimed at boosting cryptocurrency adoption through engaging offline activities. This campaign offers an exciting chance for participants to earn USDT rewards simply by introducing new users to...

Continue Reading
Trinity Capital Inc. Fuels Alt Platform's Growth with $40M Credit

Updated Category News Views 273

Trinity Capital Inc. Supports Alt with Significant Credit Facility Trinity Capital Inc. (NASDAQ: TRIN), a prominent alternative asset manager, is thrilled to announce a groundbreaking agreement with Alt, providing up to $40 million through an asset-based revolving credit facility. This funding aims to bolster Alt's innovative marketplace tailored for trading card...

Continue Reading
Everest Medicines Achieves Record Revenue and Growth in 2024

Updated Category News Views 506

Everest Medicines Achieves Remarkable Financial Success Everest Medicines, a groundbreaking biopharmaceutical company focused on innovative healthcare solutions, has reported remarkable financial results for the year ending December 31, 2024. With a robust revenue growth of 461%, the company stands out in the pharmaceutical industry, showcasing its resilience and dynamic...

Continue Reading